Saskia Bresch

Myasthenia gravis: the changing treatment landscape in the era of molecular therapies

Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment

Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders

Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis